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Introduction
Depression is a leading cause of disability and one of the 
most common mental disorders [1]. It is characterized by 
impaired ability to suppress competing or currently irrel-
evant mental-sets [2–8], such as distracting ruminative 
thoughts. Impairments in mental-set suppression have 
been found to predict onset and recurrence of depression, 
correlate with depressive rumination [9, 10], and mediate 
symptom severity [4, 11]. However, little is known about 
whether or how suppression impairments can be improved 
and if this would affect depressive symptomatology. This 
study aims to determine whether mindfulness training can 
improve mental-set suppression and whether such improve-
ment is associated with depressive alleviation.
Mindfulness-based cognitive therapy (MBCT) specifi-
cally targets avoiding getting caught in ruminative mental-
sets [12–14] and can prevent depressive relapse [13, 15]. 
While mindfulness training can improve cognitive func-
tioning [16] including mental-set suppression [17–19] 
primarily among healthy adults, cognition improvements 
among depressed individuals remain largely unexplored.
The current study focuses on Competitor Rule Suppres-
sion CRS [20] as a measure of mental-set suppression. 
CRS refers to suppression of mental-sets which implicate a 
response that competes with the correct or currently relevant 
response (for example, suppressing self-critical thoughts of 
giving up rather than staying focused on a difficult task). 
CRS specifically counters “troublemaking” irrelevant 
mental-sets by tagging them in episodic memory as “to-be-
suppressed” [21], thus facilitating adherence to current task 
demands. CRS is measured within a task-switching para-
digm [22, 23], in which the context and task requirements 
are in constant flux. This design permits examination of 
dynamic fine-tuning of suppression processes [20, 24, 25], 
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rather than more crude and consistent suppression of a sin-
gle process or stimulus seen in other suppression measures 
such as the Stroop [20, 26]. We hypothesized that MBCT 
will improve CRS and that such improvements will be 
linked to depressive symptom reduction.
Methods
Participants
Fifty-two participants with mild to severe depression were 
recruited (Fig. 1). Inclusion criteria included a score of 
≥11 on the 28-item Hamilton Depression Scale (HAM-D-
28; [27]), dysphoria or low mood for at least two months 
prior, no history of substance dependence or abuse, psy-
chotic features, or suicidal attempts in the past six months, 
and no prior experience with systematic mindfulness pro-
grams. Antidepressants were allowed only if doses were 
stable for ≥6 weeks. Forty participants were assigned to 
MBCT + treatment-as-usual (TAU) or wait-list + TAU. The 
first 13 participants were quasi-randomized and assigned in 
order of enrollment. Following an increase in recruitment, 
the next 27 participants were randomized after completing 
baseline testing. Groups were statistically equivalent in age 
(t(38) = 0.69, ns) and gender, meeting MDD criteria, and 
having a comorbid anxiety condition (minimal p = 0.44; 
Fisher’s exact test; Table 1). The study was approved by 
the Massachusetts General Hospital’s Institutional Review 
Board and registered at clinicaltrials.gov (NCT02457936).
Mindfulness‑based cognitive therapy program
The 8-week MBCT program was led by two MBCT teach-
ers with 8–13 years experience of teaching mindfulness-
based group programs and blind to the study’s hypotheses. 
The program followed the guidelines of Segal, Williams, 
and Teasdale [12].
Fig. 1  Participant flow
Assessed for eligibility (n=52)
Excluded (n=12)
Not meeting inclusion criteria (n= 7). 
Reasons: Recently changed 
antidepressant medication (n=2);
HAM-D-28 score below threshold 
(n=2), alcohol and substance 
dependence (n=1); psychotic 
features (n=1); significant prior 
mindfulness experience (n=1)
Declined to participate (n=5)
Analysed (pre-post data): 
BDI-II: n=12; HAM-D-28: n=16; RSS: n=15; CRS: 
n=16
Excluded from analysis (n=0)
Lost to follow-up (n=6). Reasons: Too busy 
(n=1), no reason given (n=1), uninterested due 
to discontinuing intervention (n=4)
Discontinued intervention (n=5). Reasons: Too 
busy (n=2), no reason given (n=3)
Allocated to MBCT+TAU (n=22)
♦ Received MBCT+TAU (n=22)
♦ Did not receive MBCT+TAU (n=0)
Lost to follow-up (n=6). Reasons: Too busy 
(n=3), moved to another city (n=1), no longer 
interested (n=1)
Discontinued TAU (n=0)
Allocated to Wait-list+TAU (n=18)
♦ Received TAU (n=18)
♦ Did not receive TAU (n=0)
Analysed (pre-post data):
BDI-II: n=13; HAM-D-28: n=9; RSS: n=9; CRS: 
n=11
Excluded from Task Switching analysis (n=1;
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The Mini International Neuropsychiatric Interview [28] ver-
sion 5.0.0 and the HAM-D-28; [27, 29] were administered by 
trained and certified psychiatrists and psychologists from Mass. 
General Hospital to assess inclusion criteria. The Beck Depres-
sion Inventory-II (BDI-II [30]) was administered 0–2 weeks 
prior to the MBCT program and every 2–3 weeks during the 
program to measure changes in depressive symptoms. The 
Rumination Response Scale was also administered. These data 
are detailed in the electronic supplementary material.
Competitor rule suppression
CRS was assessed via a task-switching paradigm based on 
[31] (Fig. 2). Briefly, a text-cue indicated which of three 
tasks was to be performed (“Amount” to indicate whether 
one or three objects are presented, “Filled-In” to indicate 
whether the object is filled with color or not, or “Smooth-
ness” to indicate whether the object’s outline is smooth or 
bumpy). Tasks were presented in random order, with no 
repetition on two consecutive trials in order to maximize 
the number of CRS trials [19, 20]. Participants completed 
20 practice trials, followed by three experimental blocks of 
120 trials each. CRS was calculated by subtracting reac-
tion time (RT) and error rates in trials in which the cur-
rent rule was not the competing rule in the previous trial 
(non-CRS trials) from trials in which the current rule was 
the competing rule in the previous trial (CRS trials; [19–
21, 32]; Fig. 2). RT analyses were performed on trials in 
which the current and last responses were correct. RT of 
over 3500 ms (ms) was excluded [19]. Information regard-
ing Backward Inhibition, an additional measure assessed 
with the same task, is detailed in the electronic supplemen-
tary material.
Procedure
Participants completed a phone screen, then signed the 
consent form, and underwent the MINI and the clinician-
rated HAM-D-28 to assess eligibility. They then completed 
the CRS task, the BDI-II, and other measures outside the 
scope of this report. Testing procedures were repeated for 
all participants 0–3 weeks after the MBCT program. Clini-
cal assessors were blind to group allocation.
Table 1  Baseline demographic and clinical characteristics of par-
ticipants (all baseline group differences are nonsignificant; minimal 
p = 0.49)
MBCT + TAU Wait-list + TAU










Meeting major depressive  
disorder criteria (%)
86 72
Comorbid anxiety disorder (%) 54 44
Fig. 2  Illustration of events in 
the task-switching paradigm. 
In the first presented trial, the 
relevant rule is “Amount” and 
correct answer is the right key. 
“Smoothness” in this trial is 
a conflicting rule as it indi-
cates the left key as the correct 
response. CRS is evident 
by hampered performance 
(indicating rule suppression) 
when on the following trial 
the previously conflicting rule 
(“Smoothness”) becomes the 
relevant rule, as in the illus-
trated example





Groups had statistically equivalent BDI-II scores at baseline, 
both when examining all participants (t(36) = 0.50, ns) and par-
ticipants with post-program data, (t(23) = 0.16, ns; Table 1). A 
one-way analysis of covariance (ANCOVA) with group as the 
independent variable conducted on post-program BDI-II scores 
while controlling for baseline BDI-II scores revealed a highly 
significant effect for group, with MBCT + TAU (M = 10.60, 
SD = 8.12) exhibiting lower BDI-II scores post-program than 
controls (M = 25.46, SD = 14.91; F(1,22) = 22.51, p < 0.001, 
ηp
2 = 0.505, 90% CI (0.23, 0.65); Fig. 3). BDI-II scores from 
week 6 were used for four participants who discontinued 
before post-testing. This effect remained highly significant 
after excluding these participants F(1,18) = 29.14, p < 0.001, 
ηp
2 = 0.618, 90% CI (0.33, 0.74).
HAM-D-28
Groups had statistically equivalent baseline HAM-D-28 
scores, both when examining all participants t(35) = 0.47, 
ns (Table 1) and when examining only participants with 
post-program data (t(23) = 0.71, ns). ANCOVA conducted 
on post-program HAM-D-28 scores while controlling for 
baseline scores revealed a significant effect for group, with 
MBCT + TAU (M = 12.63, SD = 8.76) exhibiting lower 
HAM-D-28 scores post-program than wait-list + TAU 
(M = 20.44, SD = 6.35), F(1,22) = 4.77, p < 0.05, 
ηp
2 = 0.178, 90% CI (0.005, 0.39; Fig. 3).
CRS
Groups were equivalent at baseline in reaction time (RT; 
t(38) = 0.36, ns) and error rates (t(38) = 1.00, ns) when 
including all participants and when including only par-
ticipants with post-program data (maximal t(25) 1.38, 
ns). An ANCOVA with group as the independent vari-
able conducted on post-program RT while controlling 
for baseline RT revealed a significant effect for group, 
with the MBCT + TAU group (M = 44 ms, SD = 77 ms) 
exhibiting an increased CRS effect compared to the con-
trol group (M = −41 ms, SD = 109 ms; F(1,24) = 6.13, 
p = 0.02, ηp2 = 0.20, 90% CI (0.02, 0.40); Fig. 4). A simi-
lar ANCOVA conducted on post-program error rates while 
controlling for baseline error rates did not reach signifi-
cance (F(1,24) = 1.57, ns).
The relationship between CRS and depressive 
symptoms
Multiple regression was used to predict change in BDI-II 
based on change in CRS error rates and RT. A significant 
regression model was found (F(1,19) = 6.91, p = 0.02) 
with change in error rates associated with change in depres-
sive symptoms. The multiple correlation coefficient was 
0.52, indicating that overall improvement in irrelevant men-
tal-set suppression explained 26.7% of the variance in BDI-
II scores (β = 0.52, p = 0.02; R2 = 0.267). A similar regres-
sion was calculated with group as an additional factor. A 
significant model was found (F(2,18) = 19.20, p < 0.001), 
with a multiple correlation coefficient of 0.82 (R2 = 0.64). 
Group (β = 0.68, p < 0.001) was a significant factor and 
error rates just attained significance (β = 0.30, p = 0.05).
Fig. 3  ANCOVAs of BDI-II and HAM-D-28 scores post-program 
with baseline scores as covariates; **F(1,22) = 22.51, p < 0.001; 
*F(1,22) = 4.77, p < 0.05
Fig. 4  ANCOVA of CRS in RT post-program with baseline scores as 
a covariate; *F(1,24) = 6.13, p = 0.02
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Discussion
This study found significantly lower depression scores and 
significantly higher CRS following MBCT compared to 
wait-list + TAU. Moreover, improvements in CRS were 
significantly associated with improvements in BDI-II 
scores. These results constitute the first empirical evidence 
indicating MBCT can help improve mental-set suppression, 
as well as the first evidence linking such improvements to 
depressive alleviation.
CRS has been labeled “smart inhibition” [33] since it meas-
ures the ability to detect and target only conflicting and “trou-
blemaking” mental-sets. CRS operates on a higher order and 
abstract level than most inhibition measures in the sense that 
it does not merely involve suppression a competing response 
but of a competing rule, regardless of the specific response 
[20, 21]. This type of finely tuned suppression mechanism fits 
particularly well with the mindfulness training practiced in 
MBCT, which focuses on avoiding getting caught in depres-
sion-related thoughts that often conflict with one’s ability 
to focus on current task demands. Our findings suggest that 
reductions in depressive symptoms are associated with such 
specialized and specific suppression. These benefits following 
improved specific suppression contrast with broad and more 
general thought suppression among depressed individuals, 
which may prolong or worsen depressive symptoms [34, 35].
The primary limitation of this study was the small sam-
ple. Possibly some null effects would have reached signif-
icance in a larger sample. The small sample is somewhat 
less problematic with regard to the significant differences 
found in this study, since the more probable statistical error 
in this case is of type I. Second, the use of a wait-list rather 
than an active control program limits us to only attribute 
findings to the MBCT program as a whole, rather than to 
mindfulness training specifically. Finally, although group 
assignment for most participants was random, the first few 
participants were quasi-randomized by enrollment order.
Although the current results should be confirmed in 
larger samples, they provide preliminary evidence that 
MBCT can improve mental-set suppression, a key cogni-
tive deficit in depression. Furthermore, these findings dem-
onstrate that these improvements in are associated with 
improvements in depressive symptoms.
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